Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$623M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$615M |
| 3 |
IBM
IBM
|
+$448M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$368M |
| 5 |
Wells Fargo
WFC
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$791M |
| 2 |
EMC CORPORATION
EMC
|
+$736M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$501M |
| 4 |
Mondelez International
MDLZ
|
+$492M |
| 5 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$391M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.13% |
| 2 | Technology | 9.71% |
| 3 | Financials | 8.96% |
| 4 | Healthcare | 8.95% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5801
DELISTED
GS Connect S&P GSCI Enhanced Commodity Total Return Strategy Index ETN (maturity subject to postpone
GSC
| $18K | ﹤0.01% |
829
-2,763
| -77% | -$58.5K |
2015 Q4
3 quarters
|
|
5802
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.98M
| $17K | ﹤0.01% |
67
+21
| +46% | +$5.57K |
2014 Q2
9 quarters
|
|
5803
Eagle Point Credit Company
ECC
$379M
| $17K | ﹤0.01% |
1,000
+600
| +150% | +$10.3K |
2016 Q2
1 quarter
|
|
5804
ChronoScale Holdings
CHRN
$2.17B
| $17K | ﹤0.01% |
+16
| New | +$14.2K |
2016 Q3
0 quarters
|
|
5805
Gencor Industries
GENC
$263M
| $17K | ﹤0.01% |
1,414
+1,043
| +281% | +$11.9K |
2016 Q1
2 quarters
|
|
5806
Global Industrial
GIC
$1.67B
| $17K | ﹤0.01% |
+2,104
| New | +$17.7K |
2016 Q3
0 quarters
|
|
5807
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$30.7M
| $17K | ﹤0.01% |
+81
| New | +$17.2K |
2016 Q3
0 quarters
|
|
5808
ICL Group
ICL
$6.44B
| $17K | ﹤0.01% |
4,390
+1,620
| +58% | +$6.58K |
2014 Q3
8 quarters
|
|
5809
Lifeway Foods
LWAY
$333M
| $17K | ﹤0.01% |
956
-841
| -47% | -$10.2K |
2013 Q2
13 quarters
|
|
5810
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$10.8M
| $17K | ﹤0.01% |
+86
| New | +$17.8K |
2016 Q3
0 quarters
|
|
5811
DELISTED
Vaxart
VXRT
| $17K | ﹤0.01% |
813
-611
| -43% | -$9.66K |
2013 Q2
13 quarters
|
|
5812
Zevra Therapeutics
ZVRA
$607M
| $17K | ﹤0.01% |
237
-9
| -4% | -$640 |
2015 Q2
5 quarters
|
|
|
HSTO
5813
DELISTED
Histogen Inc. Common Stock
HSTO
| $17K | ﹤0.01% |
42
-3
| -7% | -$1.22K |
2013 Q3
12 quarters
|
|
|
ALSK
5814
DELISTED
Alaska Communications Systems
ALSK
| $17K | ﹤0.01% |
9,831
-2,767
| -22% | -$4.68K |
2013 Q2
13 quarters
|
|
|
AREX
5815
DELISTED
Approach Resources Inc.
AREX
| $17K | ﹤0.01% |
4,864
-27,112
| -85% | -$68.6K |
2013 Q2
13 quarters
|
|
|
GTWN
5816
DELISTED
Georgetown Bancorp, Inc.(MA)
GTWN
| $17K | ﹤0.01% |
798
| – | – |
2013 Q4
11 quarters
|
|
|
BSPM
5817
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
| $17K | ﹤0.01% |
4,651
+4,627
| +19,279% | +$16.9K |
2013 Q4
11 quarters
|
|
|
SDR
5818
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
| $17K | ﹤0.01% |
12,050
-2,507
| -17% | -$3.95K |
2013 Q2
13 quarters
|
|
|
KROO
5819
DELISTED
IQ Australia Small Cap ETF
KROO
| $17K | ﹤0.01% |
1,002
+751
| +299% | +$12.5K |
2013 Q2
13 quarters
|
|
|
IRV
5820
DELISTED
SPDR S&P International Materials Sector
IRV
| $17K | ﹤0.01% |
853
-97
| -10% | -$1.88K |
2013 Q4
11 quarters
|
|
|
FBRC
5821
DELISTED
FBR & Co. Common Stock
FBRC
| $17K | ﹤0.01% |
1,309
+287
| +28% | +$4.12K |
2013 Q2
13 quarters
|
|
|
ICI
5822
DELISTED
iPath Optimized Currency Carry ETN
ICI
| $17K | ﹤0.01% |
416
| – | – |
2015 Q4
3 quarters
|
|
5823
iShares JPMorgan EM Corporate Bond ETF
CEMB
$422M
| $16K | ﹤0.01% |
321
| – | – |
2014 Q4
7 quarters
|
|
5824
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$117M
| $16K | ﹤0.01% |
1,511
-396
| -21% | -$4.22K |
2015 Q4
3 quarters
|
|
5825
Crescent Biopharma
CBIO
$467M
| $16K | ﹤0.01% |
22
+17
| +340% | +$13K |
2015 Q1
6 quarters
|
|
Similar funds
Morgan Stanley's Q3 2016 Portfolio in Review
As of Q3 2016, Morgan Stanley held 6,800 positions worth $293B, up 5.8% from $277B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Morgan Stanley's Q3 2016 filing shows 189 new, 3,183 increased, 2,670 reduced and 222 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $791M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2016 buy was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M.
- Morgan Stanley added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2016, an estimated $623M increase.
- Morgan Stanley's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $791M.
- Morgan Stanley fully exited EMC CORPORATION in Q3 2016, selling an estimated $736M.
- Morgan Stanley's ten largest holdings make up 13% of its $293B portfolio in Q3 2016.
- Morgan Stanley opened 189 new positions and closed 222 in Q3 2016.
- Morgan Stanley's portfolio value rose 5.8% quarter-over-quarter to $293B.
Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.